Early safety check: psoriasis Drug's hidden effects on heart and common meds
NCT ID NCT06610890
Summary
This small, completed study aimed to understand how a potential new psoriasis drug, Hemay005, interacts with a common sedative (midazolam) in the body. It involved 20 healthy adults to check if the drug affects heart rhythm and measures of inflammation. The main goal was to gather safety and interaction data, not to treat psoriasis in participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Conditions
Explore the condition pages connected to this study.